DBI was founded by veteran neurotechnology entrepreneur Geoff Thrope and Dr. Warren Grill as a portfolio company of NDI. Their model is to invest in and develop technologies in large markets where there is at least one validated product, but where critical needs still exist. Thrope and Grill have an impressive track record in developing innovative neurodevice therapies that provide significant returns to investors. In 2008, they sold their MEDSTIM system for urinary incontinence to Medtronic, Inc. for $42 million.
Mr. Thrope serves as CEO of DBI, and President and Managing Director of NDI, a hybrid venture capital and commercialization firm that focuses on innovative neurodevice technologies to address significant unmet health conditions. He has more than 30 years of neurodevice experience conducting academic research and leading commercial product development, sales and marketing and business development in the neurodevice industry. Click here to learn more.
Dr. Grill is leading ongoing development of DBI’s innovative temporal patterns of brain stimulation and is the lead inventor of the patents that DBI is exclusively licensing from Duke. Dr. Grill is also co-founder and chief scientific officer of NDI Medical. He is the Addy Professor of Biomedical Engineering at Duke, with secondary appointments in Neurobiology and Surgery. Click here to learn more.
Bob Strother is an expert in the design, development, testing and manufacture of medical devices, including class III active implantable medical devices (AIMD). He has been instrumental in the design and commercial implementation of neurostimulation systems for over 30 years. Click here to learn more.